UNH Research Note — Recovery Still Has Conditions
UnitedHealth has two quarters of medical-cost improvement, but the recovery remains narrow and legal risk is unresolved.
UNH
UNH Deep Coverage Review — Analysis as of August 10, 2026
UnitedHealth has two quarters of medical-cost improvement, while flat revenue, weaker Optum results and federal scrutiny keep the recovery conditional.
UNH Research Note — Better Headlines, Unresolved Costs
UnitedHealth’s better quarter did not settle the medical-cost debate as the shares reversed sharply despite broader health-care leadership.
UNH Deep Coverage Review — Analysis as of July 27, 2026
UnitedHealth’s valuation and dividend support the franchise, but medical-cost uncertainty and a failed breakout leave stabilization unconfirmed.